10.21.14
The ABC-AHP-NCNPR Botanical Adulterants Program (BAP), Austin, TX, has added John H. Cardellina II, PhD, as chief technical consultant and associate editor of the BAP. Dr. Cardellina is a renowned, highly respected natural products and botanicals expert. He most recently worked in research and development at McCormick & Co., Inc., where he conducted research on spice and herb quality and the development of new flavors.
The BAP is an international educational joint venture led by three nonprofit organizations: the American Botanical Council (ABC), the American Herbal Pharmacopoeia (AHP), and the National Center for Natural Products Research (NCNPR) at the University of Mississippi.
"I am excited to rejoin this important effort by ABC, AHP, and NCNPR,” said Dr. Cardellina. “Adulteration is a growing problem in the supplement and food/flavor industries. Whether intentional or unintentional, adulteration is a serious disservice to consumers. I believe the Botanical Adulterants Program is a vitally important step in combating this problem, while simultaneously educating manufacturers, suppliers, researchers, and other interested parties.”
From 2002 to 2007, Dr. Cardellina served as an expert chemist in the Screening Technologies Branch of the National Cancer Institute (NCI). Prior to that, he was vice president of botanical science and regulatory affairs at the Council for Responsible Nutrition (CRN), a leading industry trade group. Dr. Cardellina developed CRN’s comprehensive botanicals agenda, intended to guide member companies in the manufacture of safe, high-quality, beneficial herbal products. Before joining CRN in April 1998, he was a senior investigator and head of the Natural Products Chemistry Section of the NCI’s Laboratory of Drug Discovery, Research and Development.
Dr. Cardellina has published more than 195 scientific papers in peer-reviewed professional journals and has lectured extensively on issues related to natural products research and botanical products. He is a member of the American Chemical Society and the American Society of Pharmacognosy (ASP), for which he served as president from 2000 to 2001. Dr. Cardellina is on ABC’s scientific advisory board and is chair of the Board of Directors of the American Herbal Pharmacopoeia and the Board of Directors of the ASP Foundation.
The BAP is an international educational joint venture led by three nonprofit organizations: the American Botanical Council (ABC), the American Herbal Pharmacopoeia (AHP), and the National Center for Natural Products Research (NCNPR) at the University of Mississippi.
"I am excited to rejoin this important effort by ABC, AHP, and NCNPR,” said Dr. Cardellina. “Adulteration is a growing problem in the supplement and food/flavor industries. Whether intentional or unintentional, adulteration is a serious disservice to consumers. I believe the Botanical Adulterants Program is a vitally important step in combating this problem, while simultaneously educating manufacturers, suppliers, researchers, and other interested parties.”
From 2002 to 2007, Dr. Cardellina served as an expert chemist in the Screening Technologies Branch of the National Cancer Institute (NCI). Prior to that, he was vice president of botanical science and regulatory affairs at the Council for Responsible Nutrition (CRN), a leading industry trade group. Dr. Cardellina developed CRN’s comprehensive botanicals agenda, intended to guide member companies in the manufacture of safe, high-quality, beneficial herbal products. Before joining CRN in April 1998, he was a senior investigator and head of the Natural Products Chemistry Section of the NCI’s Laboratory of Drug Discovery, Research and Development.
Dr. Cardellina has published more than 195 scientific papers in peer-reviewed professional journals and has lectured extensively on issues related to natural products research and botanical products. He is a member of the American Chemical Society and the American Society of Pharmacognosy (ASP), for which he served as president from 2000 to 2001. Dr. Cardellina is on ABC’s scientific advisory board and is chair of the Board of Directors of the American Herbal Pharmacopoeia and the Board of Directors of the ASP Foundation.
